Disorders, Lymphoproliferative
1 clinical trials · Condition
◉ Watch Disorders, Lymphoproliferative
| Record | Firm | Date |
|---|---|---|
| Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas (NCT03258567) | National Cancer Institute (NCI) | 2018-04-26 |
Track Disorders, Lymphoproliferative automatically
Every clearance here is in the API, with alerts when new ones post.